Sarepta Therapeutics (SRPT)
Create an Alert
38.15
+0.39 +1.03%
NASDAQ
Jun 18, 8:00PM
BATS Real time
Currency in USD
Sarepta Therapeutics Free Cash Flow:
-15.46M for March 31, 2013Sarepta Therapeutics Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -15.46M |
| Dec. 31, 2012 | -7.581M |
| Sept. 30, 2012 | -7.886M |
| June 30, 2012 | -6.061M |
| March 31, 2012 | -9.311M |
| Dec. 31, 2011 | -6.432M |
| Sept. 30, 2011 | -7.843M |
| June 30, 2011 | -1.307M |
| March 31, 2011 | -10.40M |
| Dec. 31, 2010 | -2.393M |
| Sept. 30, 2010 | -3.26M |
| June 30, 2010 | -4.694M |
| March 31, 2010 | -6.816M |
| Dec. 31, 2009 | -2.024M |
| Sept. 30, 2009 | -2.068M |
| June 30, 2009 | -4.791M |
| March 31, 2009 | -1.911M |
| Dec. 31, 2008 | -2.910M |
| Sept. 30, 2008 | -4.408M |
| June 30, 2008 | -1.474M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
SRPT Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Regeneron Pharmaceuticals | 65.04M |
| Dendreon | -89.15M |
| ACADIA Pharmaceuticals |
SRPT Free Cash Flow Rankings
| Overall |
66th percentile 5548 of 16770 |
| Sector |
54th percentile 634 of 1408 in Healthcare |
| Industry |
56th percentile 195 of 453 in Biotechnology |
SRPT Free Cash Flow Range, Past 5 Years
| Minimum | -15.46M | Mar 2013 |
| Maximum | -1.307M | Jun 2011 |
| Average | -5.452M |
